GPO helps hospitals manage use of stents with new toolkit

Article

Premier Inc. offers Rational Choice Rx toolkit to help hospitals manage their patients who are underoing stent placement.

Hospitals that are interested in improving the management of their percutaneous coronary intervention (PCI) procedures have a new tool available to them. It's Rational Choice Rx from

Recent Videos
Related Content
Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care System

Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care System

Brian Nowosielski;Erin R. Fox, PharmD, MHA, BCPS, FASHP
January 22nd 2025
Article

Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.

Looking to the Future of Independent Pharmacy

Looking to the Future of Independent Pharmacy

Miranda Hester
July 13th 2022
Podcast

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Q&A: The Importance of ASHP’s 2025 Pharmacy Forecast

Q&A: The Importance of ASHP’s 2025 Pharmacy Forecast

Brian Nowosielski;Joseph T. DiPiro, PharmD, FCCP, FAAAS
January 17th 2025
Article

Joseph DiPiro, PharmD, FCCP, FAAAS, editor of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast, discussed key themes in the forecast that will impact health-system pharmacy in 2025.

Podcast: Pharmacy Financing With First Financial Bank

Podcast: Pharmacy Financing With First Financial Bank

January 28th 2022
Podcast

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear

Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear

Brian Nowosielski;Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP;Ashley Gallagher
January 7th 2025
Article

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.

Q&A: How Pharmacists Can Help Patients with COPD, Inhaler Misuse | ASHP Midyear

Q&A: How Pharmacists Can Help Patients with COPD, Inhaler Misuse | ASHP Midyear

Brian Nowosielski;Lourdes Cross, PharmD, BCACP, CDCES;Ashley Gallagher
December 17th 2024
Article

Drug Topics met with Lourdes Cross, PharmD, BCACP, CDCES, to discuss pharmacists’ role in managing patients’ chronic obstructive pulmonary disease.

© 2025 MJH Life Sciences

All rights reserved.